Cipla Readies gSymbicort, Semaglutide Amid Sale Speculation ‘Distraction’

"Very Small Investment” In Gene Editing/Sequencing On Cards

• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business